Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Scientific Reports|November 17, 2018
Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancerGabriele Schricker, Rudolf Napieralski, Aurelia Noske, et al.
International Journal of Cancer|July 5, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patientsKonstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou, et al.
Nature Chemical Biology|April 16, 2021
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1Thomas Kryza, Tashbib Khan, Scott Lovell, et al.
Scientific Reports|May 20, 2017
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancerTommaso De Marchi, Mieke A Timmermans, Anieta M Sieuwerts, et al.
Cancer Immunology Research|April 28, 2021
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In VivoTobias F Dreyer, Sabine Kuhn, Christoph Stange, et al.
Cellular and Molecular Life Sciences : CMLS|September 4, 2012
The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10Tamara Jefferson, Ulrich Auf dem Keller, Caroline Bellac, et al.
Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Pageof 13